Future studies that combine whole-genome activator and knockout screens in both luminal and basal bladder cancer will provide a comprehensive framework of the various positive and negative regulatory mechanisms that are necessary and/or sufficient to modulate PPARG gene expression in MIBC. This evidence concerns the gene PPARG and urinary bladder carcinoma.